20+ Years of Working Together >Complementary Product Portfolios will provide customers with a full suite of IV therapy devices and solutions + >Unified distribution channel with a full product offering for the US market as a completely ALeading Pure-Play vertically integrated supplier Infusion Therapy Company >Significant OUS Presence allows us to compete more successfully on a global scale as the Estimated ~$1.35 billion in category develops combined revenues in FY 17 Nearly 9,000 employees >Compelling Economics enabling us to provide worldwide meaningful value for customers, employees, and Significant focus and scale shareholders worldwide in the core IV business segment globally 3
{}